where R1, R2, R3, R4, R5, R6, R7 may be hydrogens, halogen atoms, (C1-C4)-alkyl groups, nitro groups; "n" can be 1-3, and their physiologically acceptable salts which are inhibitors of zinc-dependent metalloproteinases (MMP-2 and MMP-9). Also a method for preparation of compounds of formula (1) and a method for treating by remodelling of the left ventricle of the heart in the peracute phase of myocardial infarction using compounds of the formula (1) are provided.;EFFECT: increased efficiency of treatment.;4 cl, 3 dwg, 2 tbl, 3 ex"/>
公开/公告号RU2646752C2
专利类型
公开/公告日2018-03-07
原文格式PDF
申请/专利号RU20160106615
发明设计人 SEREDENIN SERGEJ BORISOVICH (RU);MOKROV GRIGORIJ VLADIMIROVICH (RU);KRYZHANOVSKIJ SERGEJ ALEKSANDROVICH (RU);LIKHOSHERSTOV ARKADIJ MIKHAJLOVICH (RU);STOLYARUK VALERIJ NIKOLAEVICH (RU);VITITNOVA MARINA BORISOVNA (RU);TSORIN IOSIF BORISOVICH (RU);GUDASHEVA TATYANA ALEKSANDROVNA (RU);GRIGORKEVICH OKSANA SERGEEVNA (RU);IONOVA EKATERINA OLEGOVNA (RU);DURNEV ANDREJ DMITRIEVICH (RU);ZHERDEV VLADIMIR PAVLOVICH (RU);
申请日2016-02-25
分类号C07D207/48;C07D211/96;A61K31/401;A61K31/445;A61P9/10;
国家 RU
入库时间 2022-08-21 12:35:46